These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22232050)

  • 21. The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease.
    Snaedal J; Johannesson T; Jonsson JE; Gylfadottir G
    Dementia; 1996; 7(1):47-52. PubMed ID: 8788082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.
    Rondanelli M; Opizzi A; Faliva M; Mozzoni M; Antoniello N; Cazzola R; Savarè R; Cerutti R; Grossi E; Cestaro B
    Nutr Neurosci; 2012 Mar; 15(2):46-54. PubMed ID: 22334085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a single transdermal nicotine dose on cognitive performance in adults with Down syndrome.
    Bernert G; Sustrova M; Sovcikova E; Seidl R; Lubec G
    J Neural Transm Suppl; 2001; (61):237-45. PubMed ID: 11771747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial.
    Gold M; Newhouse PA; Howard D; Kryscio RJ
    Neurology; 2012 Jun; 78(23):1895; author reply 1895. PubMed ID: 22665146
    [No Abstract]   [Full Text] [Related]  

  • 25. A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia.
    Haig GM; Bain EE; Robieson WZ; Baker JD; Othman AA
    Am J Psychiatry; 2016 Aug; 173(8):827-35. PubMed ID: 26940805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal nicotine modulates strategy-based attentional semantic processing in non-smokers.
    Holmes AD; Chenery HJ; Copland DA
    Int J Neuropsychopharmacol; 2008 May; 11(3):389-99. PubMed ID: 18047753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CPAP Adherence May Slow 1-Year Cognitive Decline in Older Adults with Mild Cognitive Impairment and Apnea.
    Richards KC; Gooneratne N; Dicicco B; Hanlon A; Moelter S; Onen F; Wang Y; Sawyer A; Weaver T; Lozano A; Carter P; Johnson J
    J Am Geriatr Soc; 2019 Mar; 67(3):558-564. PubMed ID: 30724333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the information processing and mood effects of a transdermal nicotine patch.
    Warburton DM; Mancuso G
    Psychopharmacology (Berl); 1998 Feb; 135(3):305-10. PubMed ID: 9498735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study.
    Vega JN; Albert KM; Mayer IA; Taylor WD; Newhouse PA
    J Cancer Surviv; 2019 Oct; 13(5):673-686. PubMed ID: 31338732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal nicotine for induction of remission in ulcerative colitis.
    McGrath J; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of nicotine on cognition are dependent on baseline performance.
    Niemegeers P; Dumont GJ; Quisenaerts C; Morrens M; Boonzaier J; Fransen E; de Bruijn ER; Hulstijn W; Sabbe BG
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1015-23. PubMed ID: 24766971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study of intravenous nicotine effects on cognitive performance in schizophrenia.
    Boggs DL; Ranganathan M; Sewell RA; Madonick S; D'Souza DC
    Schizophr Res; 2013 Oct; 150(1):323-4. PubMed ID: 23953216
    [No Abstract]   [Full Text] [Related]  

  • 33. Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.
    McClernon FJ; Hiott FB; Westman EC; Rose JE; Levin ED
    Psychopharmacology (Berl); 2006 Nov; 189(1):125-33. PubMed ID: 16977477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lowered performance in working memory and attentional sub-processes are most prominent in multi-domain amnestic mild cognitive impairment subtypes.
    Klekociuk SZ; Summers MJ
    Psychogeriatrics; 2014 Mar; 14(1):63-71. PubMed ID: 24528806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A transdermal nicotine patch is not effective for postoperative pain management in smokers: a pilot dose-ranging study.
    Olson LC; Hong D; Conell-Price JS; Cheng S; Flood P
    Anesth Analg; 2009 Dec; 109(6):1987-91. PubMed ID: 19923530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.
    Baker LD; Barsness SM; Borson S; Merriam GR; Friedman SD; Craft S; Vitiello MV
    Arch Neurol; 2012 Nov; 69(11):1420-9. PubMed ID: 22869065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nicotine on attention and inhibitory control in healthy nonsmokers.
    Wignall ND; de Wit H
    Exp Clin Psychopharmacol; 2011 Jun; 19(3):183-91. PubMed ID: 21480731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.
    Grundey J; Amu R; Ambrus GG; Batsikadze G; Paulus W; Nitsche MA
    Psychopharmacology (Berl); 2015 Jul; 232(14):2491-501. PubMed ID: 25721074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
    Buschert VC; Friese U; Teipel SJ; Schneider P; Merensky W; Rujescu D; Möller HJ; Hampel H; Buerger K
    J Alzheimers Dis; 2011; 25(4):679-94. PubMed ID: 21483095
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.